In a murine model of breast cancer, IL-12 treatment reduced the levels of MMP-9, but not MMP-2, and it also reduced tumour cell production of VEGF by up-regulation of IFN-γ production leading to the suppression of tumour angiogenesis [10,25,26]. This evidence concerns the gene VEGFA and neoplasm.